UNIVERSITY CLINIC FOR GENERAL, VISCERAL, VASCULAR AND TRANSPLANT SURGERY

New publication on MET alterations informing on therapy sensitivity

10.02.2023 -  

MET F/SVs but not genomic amplification, were highly enriched in the secondary glioblastomas (sGBM) and marked worse prognosis. Further molecular and scRNA-seq analysis revealed that MET F/SVs were induced in the course of glioma evolution and highly associated with MET overexpression. Subsequent in vitro and the clinical study showed that cells and patients harboring MET F/SVs have better response to MET inhibitors. See the paper.

Last Modification: 27.03.2023 - Contact Person:

Sie können eine Nachricht versenden an: Webmaster
Sicherheitsabfrage:
Captcha
 
Lösung: